Stay updated on Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-20T05:00:29.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1. The study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-13T07:49:46.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 appears in the Study Record Versions, indicating the latest update to the record history. This reflects administrative versioning rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-09-22T02:27:55.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.6, was added to the Record History, replacing the previous v3.6.5, signaling a software update to the page.
    Difference
    0.1%
    Check dated 2026-08-31T23:29:11.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    A new revision label v3.6.5 was added to the record history and the previous v3.6.4 label was removed, updating the revision trail for the study record.
    Difference
    0.1%
    Check dated 2026-08-10T12:45:13.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.4 was added to the record history, replacing the previous v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-27T06:24:53.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.